Project Grant W81XWH2110077
Award Date
5/15/21
Completion Date
5/14/24
Dollars Obligated
$539K
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The Trustees of Columbia University in New York City will receive $486,000 under a two-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research into novel regulators of lineage plasticity in castration-resistant prostate cancer. Through this funding, Columbia University researchers will investigate medical solutions for prostate cancer that persists despite hormone therapy, with the goal of transforming...
The Trustees of Columbia University in the City of New York received a three-year, $729,000 Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Under this award, Columbia University will conduct research from March 2021 to February 2024 to decipher the mechanisms that drive breast...
The Trustees of Columbia University in New York City will receive $729,000 from the Department of the Army Medical Command under a three-year Project Grant award titled "Eliminating Minimal Residual Disease After Targeted Therapy in Breast Cancer." The grant is part of the Military Medical Research and Development program administered by the agency, with a focus on transforming health care for service members and the public through innovative biomedical research. Under the award,...
The Trustees of Columbia University in New York City will receive $567,000 from the Department of the Army Medical Command under a three-year Project Grant award to identify epigenetic vulnerabilities in peripheral T-cell lymphomas. The grant period runs from September 1, 2022 through August 31, 2025. The funding supports research conducted under the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health through innovative biomedical...
This Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $1,480,500.00 to The Trustees of Columbia University in the City of New York to develop a peptide-based drug delivery system targeting metastatic prostate cancer. The project will run from September 15, 2023 to September 14, 2026. The Department of Defense grant supports basic, applied, and advanced biomedical research with the goal of transforming healthcare for...
The Trustees of Columbia University in the City of New York will receive $1,619,986 from the Department of the Army Medical Command under a two-year Project Grant award to support preclinical characterization of Prosetin, a brain-penetrant MAP4K inhibitor for treating ALS. The grant was awarded on May 1, 2021 under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,645,000.00 to The Trustees of Columbia University in the City of New York to research treating HER2 therapy-resistant brain metastasis using antidepressants. The award commenced on July 1, 2025 and is scheduled for completion on June 30, 2028. As a leading academic research institution, Columbia University will leverage its extensive expertise in...
The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
The Trustees of Columbia University in New York City will receive $809,262 from the Department of the Army Medical Command under a Project Grant award to support preclinical characterization of AZVIII-7-18, a novel Paullone derivative for the treatment of ALS. The funding period is from July 1, 2022 to June 30, 2024. The award is being made through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research aimed at...
The Trustees of Columbia University in the City of New York received a $1.9 million Project Grant award from the Department of the Army Medical Command on August 15, 2022 to fund research on Protein Transduction Therapy for Acute Respiratory Distress Syndrome (ARDS). The research will be conducted through August 14, 2025 in New York, NY under the Military Medical Research and Development program (CFDA 12.420). This program supports basic, applied, and advanced biomedical research with the...